Delivery Order SPE2DB24D1104-SPE2DB24FYDJ4

Award Date 9/25/24
Potential Completion Date 10/17/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $1,624.37 and involves the delivery of 1,500 units of the KEDRAB 10 ML vial, a specialty medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a wide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.40, is for the supply of 1,500 units of the drug KEDRAB (10 mL vial) with a performance period ending on April 29, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,361.04 contract is for the delivery of 1,500 units of the 10 mL vial product KEDRAB, with a completion date of January 22, 2025. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,500 units of the drug KEDRAB, a 10 ML vial, with a ceiling value of $1,626.70. The contract has a firm fixed price pricing type and a period of performance ending on March 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $1,626.70 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,500 units of the medication KEDRAB, a 10 ml vial. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
The U.S. government awarded a $3,248.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,500 units of KEDRAB 10 mL vials. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support...
This is a $1,624.38 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 1,500 units of the drug KEDRAB, a 10 ML vial, with a completion date of June 11, 2024. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.40, is for the delivery of 1,500 units of the KEDRAB 10 ML Vial product. The contract is a Firm Fixed Price, Delivery Order type with a period of performance through March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract has a firm fixed price of $1,297.04 and a period of performance ending on August 16, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial of the drug, with a ceiling value of $24,365.55 and an ultimate completion date of August 26, 2024. The contract is a firm-fixed-price, delivery order type with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYDJ4
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,248.74 contract is for the delivery of 1,500 units of the pharmaceutical product KEDRAB (10 ML vial). The delivery order falls under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract valued at up to $999,999,999 through December 2025, which provides a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by October 17, 2024.

Generated 12/25/24, 9:01 AM